Search

Your search keyword '"Robert C. Rintoul"' showing total 214 results

Search Constraints

Start Over You searched for: Author "Robert C. Rintoul" Remove constraint Author: "Robert C. Rintoul"
214 results on '"Robert C. Rintoul"'

Search Results

1. Smoking-associated gene expression alterations in nasal epithelium reveal immune impairment linked to lung cancer risk

2. Integrated genomics point to immune vulnerabilities in pleural mesothelioma

3. Author Correction: Integrated genomics point to immune vulnerabilities in pleural mesothelioma

4. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

5. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

6. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

7. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers

8. Systematic Analysis of Splice-Site-Creating Mutations in Cancer

9. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

10. Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types

11. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

12. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

13. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types

14. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

15. Diagnostic Accuracy of a Convolutional Neural Network Assessment of Solitary Pulmonary Nodules Compared With PET With CT Imaging and Dynamic Contrast-Enhanced CT Imaging Using Unenhanced and Contrast-Enhanced CT Imaging

16. Mesothelioma and Radical Surgery 2 (MARS 2): protocol for a multicentre randomised trial comparing (extended) pleurectomy decortication versus no (extended) pleurectomy decortication for patients with malignant pleural mesothelioma

17. Table S6 from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

18. Supplementary Figures 1 - 2, Tables 1 - 3 from The UK Lung Screen (UKLS): Demographic Profile of First 88,897 Approaches Provides Recommendations for Population Screening

19. Data from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

20. Supplementary Data from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

22. Supplementary Figure 1 from CD133+ Cancer Stem-like Cells in Small Cell Lung Cancer Are Highly Tumorigenic and Chemoresistant but Sensitive to a Novel Neuropeptide Antagonist

23. Data from CD133+ Cancer Stem-like Cells in Small Cell Lung Cancer Are Highly Tumorigenic and Chemoresistant but Sensitive to a Novel Neuropeptide Antagonist

25. Single-cell transcriptomic analysis of human pleura reveals stromal heterogeneity and informs in vitro models of mesothelioma

26. A tumour-promoting senescent secretome triggered by platinum chemotherapy exploits a targetable TGFβR1/Akt-mTOR axis in lung cancer

27. Respiratory cytology in malignant lung disease – The thoracic oncologist’s perspective

28. Biological basis for novel mesothelioma therapies

29. Challenges and opportunities for conducting a vaccine trial during the COVID-19 pandemic in the United Kingdom

30. Determinants of expression of SARS-CoV-2 entry-related genes in upper and lower airways

31. Integrated genomics point to immune vulnerabilities in pleural mesothelioma

32. Smoking-dependent expression alterations in nasal epithelium reveal immune impairment linked to germline variation and lung cancer risk

33. S98 Dissecting human pleura at single-cell resolution

34. ctDNA detection by personalised assays in early-stage NSCLC

35. Impact of solitary pulmonary nodule size on qualitative and quantitative assessment using 18F-fluorodeoxyglucose PET/CT:the SPUTNIK trial

36. Multimodality Approaches to Screening for Lung Cancer

37. Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial

38. A hypercoagulable state leading to venous limb gangrene associated with occult lung adenocarcinoma

39. SARS-CoV-2-induced senescence as a potential therapeutic target

40. Communicating uncertainty:contrasting the communication experiences of patients with advanced COPD and incurable lung cancer

41. Use of preclinical models for malignant pleural mesothelioma

42. Biomarkers in lung cancer screening: the importance of study design

43. Lesson of the month: novel method to quantify neutrophil uptake in early lung cancer using SPECT-CT

44. Determinants of SARS-CoV-2 receptor gene expression in upper and lower airways

45. ctDNA monitoring using patient-specific sequencing and integration of variant reads

46. Dynamic contrast-enhanced computed tomography for the diagnosis of solitary pulmonary nodules: a systematic review and meta-analysis

47. Integrated genomics identify novel immunotherapy targets for malignant mesothelioma

48. Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis

49. Adenocarcinoma spectrum lesions of the lung: Detection, pathology and treatment strategies

50. Lung cancer treatment during a pandemic: how have multi-disciplinary teams changed?

Catalog

Books, media, physical & digital resources